Human peptidyl arginine deiminase 2 SMAR…

The University of Nebraska Medical Center (UNMC) in Omaha, Nebraska, has issued a purchase order (PO) 4800161471 to Horizon Discovery Biosciences Ltd, a vendor based in Cambridge, United Kingdom. The contract, valued at $534.00, involves the procurement of one unit of "Human peptidyl arginine deiminase 2 SMAR," a specialized scientific research product. The delivery is scheduled for December 9, 2025, with shipping directed to UNMC's facility located at 601 S Saddle Creek Rd, Omaha, NE 68198.

The purchase order, executed on November 26, 2025, is structured with Net/Receipt of Goods/Invoice terms and F.O.B. destination provisions. The specific delivery point is designated to Erin McIntyre at LTC 11727, indicating an internal routing within the medical center's research infrastructure. The contract is governed by the University of Nebraska's Standard Terms of Purchase and maintains a tax-exempt status under identification number 05-8905401. The brief performance period—from award to completion—spans approximately two weeks, suggesting a focused, targeted procurement of scientific research materials.